Clinical Trials Browser

Phase 1/2 × Solid Tumors × Other solid neoplasm × Clear all

NCT04174716 2026-04-17

VASTUS

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06885281 2026-04-09

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT03917381 2026-04-06

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT06873789 2026-03-25

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT05101070 2026-03-18

aCCeleR8-001

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT04627740 2026-01-20

Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT07231211 2026-01-09

A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07265622 2025-12-29

First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07105215 2025-11-26

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07055594 2025-11-06

NbTAST-01

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07158918 2025-09-08

ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT04685226 2025-09-02

A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06992687 2025-05-28

A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors

Phase 1/2 Enrolling by invitation

Other solid neoplasm

Solid Tumors

NCT06955390 2025-05-02

Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06947226 2025-04-27

A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06928363 2025-04-15

A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT02240238 2025-01-22

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

Phase 1/2 Completed

119 enrolled 24 charts

Other solid neoplasm

Solid Tumors

NCT06764628 2025-01-22

A Study of SHR-4375 in Subjects With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT05416749 2024-11-20

A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Suspended

Other solid neoplasm

Solid Tumors

NCT01283945 2024-07-25

Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT06233292 2024-06-14

A Study of ZG005 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT02598960 2023-03-06

An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.

Phase 1/2 Completed

295 enrolled 28 charts

Other solid neoplasm

Solid Tumors

NCT05740215 2023-02-22

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT02593786 2022-10-24

CheckMate 077

Phase 1/2 Completed

58 enrolled 31 charts

Other solid neoplasm

Solid Tumors

NCT03965845 2022-09-19

A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasmThoracic

Solid Tumors

NCT02639546 2022-09-16

iMATRIXcobi

Phase 1/2 Completed

56 enrolled 31 charts

Other solid neoplasm

Solid Tumors

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT02303028 2022-06-28

TOPAZ

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT05216965 2022-06-15

A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT04937842 2021-06-24

Microtransplantation for Advanced and Relapsed Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT02587962 2021-01-14

Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors

Phase 1/2 Terminated

34 enrolled 27 charts

Other solid neoplasm

Solid Tumors

NCT03035591 2019-10-15

BETIDES

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT01949688 2019-03-19

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A24 or A02-positive Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT02858232 2016-08-11

MASCT-I Treatment for Advanced Solid Tumor

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT00703378 2012-03-28

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors